are in good agreement, the deacylation step being rate limiting in catalysis. The pH-dependence of k +2 /K s , k +2 , and K s reflects the acidic pK a shift of the Tyr411 catalytic residue from 9.0 ± 0.1 in the substrate-free HSA to 8.1 ± 0.1 in the HSA:NphOAc complex. Accordingly, diazepam inhibits competitively the HSA-catalyzed hydrolysis of NphOAc by binding to Tyr411.
Introduction
The three-domain organization of HSA is at the root of its capability to bind not only endogenous and exogenous low molecular weight compounds but also peptides and proteins at multiple sites. Remarkably, 35 proteins have been found to be associated to HSA under physiological conditions; the fraction of peptides and proteins bound to HSA has been defined as ''albuminome'' [1] [2] [3] [4] [5] [6] .
Upon binding endogenous and exogenous (macro)molecules, HSA undergoes chemical modifications, including acetylation, cysteinylation, homocysteinylation, glutathionylation, glycosylation, glycation, nitrosylation, nitration, oxidation, phosphorylation, biotinylation, and chlorination [6] ; remarkably, chemical modifications may affect HSA binding properties and may confer antigenicity properties [1, 6, 7] .
In addition to its reversible and irreversible ligand binding capabilities, HSA displays pseudo-enzymatic properties. In fact, most of the apparent enzymatic properties of HSA (e.g., esterase activity) are the result of multiple irreversible chemical modifications rather than of the catalytic activity occurring at a single reactive site [8] . Remarkably, the apparent HSA-catalyzed hydrolysis of 4-nitrophenyl acetate (NphOAc) is the result of the irreversible acetylation of 82 residues rather than of turnover. In fact, only Tyr411 is acetylated within the first 5 min of reaction with 5.0 Â 10 À4 M NphOAc; after 30 min to 6 h, the partial acetylation of additional 16-17 residues of HSA takes place, including Asp1, Lys4, Lys12, Tyr411, Lys413, and Lys414. HSA incubation with 1.0 Â 10 À2 M NphOAc results in the acetylation of 59 Lys, 10 Ser, 8 Thr, 4 Tyr, and 1 Asp [8] .
Here, kinetics of the HSA pseudo-enzymatic hydrolysis of NphOAc, obtained under conditions where [HSA] P 5Â [NphOAc] and [NphOAc] P 5Â[HSA] (between pH 5.8 and 10.2, at 22.0°C), are reported. The pH-dependence of the rates of the individual steps for the HSA pseudo-esterase activity probably depends on the acid-base equilibrium of Tyr411 and parallels the neutral-tobasic allosteric transition. Accordingly, diazepam inhibits competitively the HSA-catalyzed hydrolysis of NphOAc by binding to Tyr411. [(1,1-dimethyl-2-hydroxyethyl)amino]-2-hydroxypropanesulfonic acid (AMPSO), and 2-amino-2-methyl-1-propanol were obtained from Sigma-Aldrich (St. Louis, MO, USA). All chemicals were of analytical or reagent grade and were used without further purification.
Materials and methods

HSA
HSA (from Sigma-Aldrich, St. Louis, MO, USA) was essentially fatty acid free, according to the charcoal delipidation protocol [9] [10] [11] .0°C, were analyzed in the framework of the minimum three step-mechanism reported in Scheme 1 [8, [12] [13] [14] [15] , where HSA is the substrate-free protein, NphOAc is the substrate, HSA:NphOAc is the reversible protein-substrate complex, HSA-OAc is considered to be an ester formed between the acyl moiety of the substrate and the O atom of the Tyr411 phenoxyl group [8] , AcOH is acetic acid, k +l is the second-order rate constant for the formation of the HSA:NphOAc complex starting from HSA and NphOAc, k À1 is the first-order rate constant for the dissociation of the HSA:NphOAc complex to HSA and NphOAc, K s (=k À1 /k +1 ) is the pre-equilibrium constant, k +2 is the first-order acylation rate constant, k À2 is the first-order rate constant for the conversion of HSA-OAc to HSA:NphOAc, k +3 is the first-order deacylation rate constant, and k À3 is the second-order rate constant for the formation of the HSA-OAc adduct starting from HSA and AcOH.
Kinetics and thermodynamics of the HSA-catalyzed hydrolysis of NphOAc, at pH 7.5 and 22.0°C, were also determined in the presence of diazepam ranging between 1.0 Â 10 À5 M and 7.7 Â 10 À5 M. The HSA concentration was 4.0 Â 10 À6 M and the NphOAc concentration ranged between 1.0 Â 10 À5 M and 8.0 Â 10 À5 M [16] . Kinetics and thermodynamics of the HSA pseudo-esterase activity were analyzed using the GraphPad Prism program (GraphPad Software, Inc., La Jolla, CA, USA). The results are given as mean values of at least four experiments plus or minus the corresponding standard deviation.
Results and discussion
The determination of kinetic parameters of Scheme 1 is simplified by the fact that the formation of the HSA:NphOAc complex from HSA and NphOAc may be regarded as being at equilibrium throughout the reaction (i.e., k À1 >> k +2 ; see Scheme 1). This pseudo-first-order process is characterized by the rate constant k 1 obs given by Eq. (1):
Evidence for this is based on the observation that under all the present experimental conditions no lag phase occurs in the release of NphOH from NphOAc in the presence of HSA (see Fig. 1 ). This means that the equilibration of HSA:NphOAc with HSA and NphOAc is complete within 1.1 ms (i.e., the ''dead-time'' of the rapid-mixing stopped-flow apparatus), therefore k 1 obs P 3. 
The reaction of HSA with NphOAc is a first-order process for more than 95% of its course (Fig. 1, panel A) and values of k app are independent of the observation wavelength over the whole range explored (i.e., between 350 and 450 nm) at fixed NphOAc concentration. Moreover, values of k app are independent of the NphOAc concentration when [HSA] P 5Â [NphOAc] . Values of k +2 and K s (see Table 1 ) were determined by Eq. (2) from hyperbolic plots of k app versus [HSA], as shown in Fig. 1 (panel B) .
When [NphOAc] P 5Â[HSA], a mono-exponential time course preceding the apparent very slow pseudo-steady-state process occurs (Fig. 1, panel C) . When k +2 P 5 Â k +3 , the differential equations arising from Scheme 1 may be solved [14] to describe the time course of NphOH release in the early stages of the reaction. The resulting expression is given in Eqs. (3)- (5):
where
and k obs ¼ ðk þ2 Â ½NphOAcÞ=ðK s þ ½NphOAcÞ þ k þ3 ð5Þ
As predicted from Eqs. (3)- (5) Table 1 ) were determined by Eq. (5) from hyperbolic plots of k obs versus [S], as shown in Fig. 1 (panel D) . Under all the experimental conditions, the y-intercept of the hyperbola described by Eq. (5) approximates to 0 s À1 , thus indicating that the value of k +3 is at least 100-fold smaller than the k obs value obtained at the lowest NphOAc concentration (i.e., k +3 < 10 À5 s
À1
). Accordingly, k +3 for Tyr411-OAc deacylation corresponds to 3.2 Â 10 À6 s
, at pH 8.0 and 22.0°C [8] .
As predicted by Table 1 ). Moreover, data here reported indicate that the deacylation process is rate limiting in the HSA-catalyzed hydrolysis of NphOAc (i.e., k +3 << k +2 ). Lastly, values of K s and k +2 here obtained are in agreement with those previously reported [12, 13] .
Accounting for values of K s = 2.9 Â 10 À4 M (present study), k +2 = 8.9 Â 10 À1 s À1 (present study), and k +3 = 3.2 Â 10 À6 s À1 [8] , values of K m (ffi1 Â 10 À9 M) and k cat (ffi3 Â 10 À6 s À1 ) for the HSAcatalyzed hydrolysis of NphOAc have been estimated at pH 8.0 and 22.0°C, according to Eqs. (6) and (7): 
ÀpH þ 10 ÀpKunl Þ=ð10 ÀpH þ 10 ÀpKlig ÞÞ ð8Þ According to linked functions [14] [15] [16] , the pH-dependence of k +2 /K s and k +2 reflects the acid-base equilibrium of a single amino-acid residue in the substrate-free HSA (i.e., pK unl = 9.0 ± 0.1) and in the HSA:NphOAc complex (i.e., pK lig = 8.1 ± 0.1), respectively. Moreover, the pH-dependence of K s reflects the acidic pK a shift of a single amino-acid residue from the substrate-free HSA (i.e., pK unl = 9.0 ± 0.1) to the HSA:NphOAc complex (i.e., pK lig = 8.1 ± 0.1). The pK unl value here reported is in agreement with that given in the literature [12, 13] . As expected, the pK unl value is substrate-independent (see present study and [17] ); on the other hand, the pK lig value depends on the chemical structure of the substrate (see present study and [17] ), reflecting the different solvent accessibility of the ionization group(s) modulating catalysis.
The acidic pK a shift of an apparently single ionizable side chain group of HSA upon NphOAc binding could reflect the reduced solvent accessibility of Tyr411, representing the primary esterase site of HSA (see [8, 13, 17] ), although long range effects could not be excluded.
Tyr 411 is located in the FA3-FA4 cleft that is made of a mainly apolar region forming the FA3 site and a polar patch contributing the FA4 site. The polar patch is centered on Tyr411 and includes Arg410, Lys414, and Ser489 [5, 15] . The analysis of the threedimensional structure of the ligand-free HSA [19] and of the molecular model of the HSA:4-nitrophenyl propionate complex [13] suggests that the observed pH effects (Fig. 2) could reflect the acidic pK a shift of Tyr411. This would render more stable the negative charge on the phenoxyl oxygen atom of Tyr411, which indeed appears to form a hydrogen bond with the carbonyl oxygen atom of 4-nitrophenyl propionate [13] , potentiating its nucleophilic role as an electron donor in the pseudo-esterase activity of HSA.
In order to highlight the role of Tyr411, located in the FA3-FA4 cleft [18] , as the primary esterase site for the HSA-catalyzed hydrolysis of NphOAc [8, 13, 17] , the inhibitory effect of diazepam has been investigated under conditions where [NphOAc] > [HSA]. In fact, diazepam binds at the center of the FA3-FA4 cleft with one oxygen atom interacting with the hydroxyl group of Tyr411 [18] . As expected for the pure competitive inhibition mechanism [20] 
allowed to determine the value of the equilibrium constant for diazepam binding to HSA (i.e., K I , corresponding to the absolute value of the x intercept of the linear plot). The value of K I here determined agrees with that reported previously [17, 21] . These data agree with the view that Tyr411 located at the FA3-FA4 cleft [18] is the primary esterase site for the HSA-catalyzed hydrolysis of NphOAc [8, 13] .
Conclusion
The reaction of NphOAc with HSA is reminiscent of that observed for acylating agents with other proteins (e.g., cysteine and serine proteinases) [14, 22] . However, the HSA-catalyzed hydrolysis of NphOAc is the result of the irreversible acetylation of 82 residues rather than of turnover [8] . Remarkably, the reaction of Tyr411 with NphOAc proceeds much faster than that catalyzed by any other amino-acid side chain of HSA [8, 13] .
Present data support the following considerations: (i) The hydrolysis of NphOAc by Tyr411, i.e. the most reactive group of HSA, appears to involve strong reversible binding prior to reaction.
(ii) NphOAc acts as a suicide substrate, the value of the deacylation rate constant (i.e., k +3 ) being lower by several orders of magnitude than that of the acylation rate constant (i.e., k +2 ). (iii) The hydrolysis of NphOAc by HSA is inhibited competitively by diazepam, since both the substrate and the drug interact with Tyr411 at the FA3-FA4 cleft. (iv) The ionization state of Tyr411 modulates NphOAc hydrolysis; indeed substrate binding to HSA induces the acidic pK a shift of the Tyr411 residue. (v) HSA acylation appears relevant from the pharmacokinetic viewpoint; indeed HSA acylation by aspirin [23] , beside increasing the affinity of phenylbutazone and inhibiting bilirubin binding, reduces prostaglandin affinity, accelerating the clearance of prostaglandins and serving as an additional mechanism of the aspirin anti-inflammatory effect [24] .
